TL 383 TL 383 (Terazosin Hydrochloride 1 mg)
Pill with imprint TL 383 TL 383 is Gray, Capsule-shape and has been identified as Terazosin Hydrochloride 1 mg. It is supplied by Cadista.
Terazosin is used in the treatment of benign prostatic hyperplasia; high blood pressure and belongs to the drug class antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Terazosin 1 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for TL 383 TL 383
Terazosin Hydrochloride
- Imprint:
- TL 383 TL 383
- Strength:
- 1 mg
- Color:
- Gray
- Size:
- 16.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Antiadrenergic agents, peripherally acting
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Cadista
- Inactive Ingredients:
-
- ferrosoferric oxide
- gelatin
- lactose monohydrate
- magnesium stearate
- sodium lauryl sulfate
- titanium dioxide
- corn starch
- silicon dioxide
Note: Inactive ingredients may vary.
Labelers / Repackagers:
| NDC Code | Labeler / Repackager |
|---|---|
| 59746-0383 | Jubilant Cadista Pharmaceuticals Inc. |
| 67544-0581 | Prepak Systems Inc. (repackager) |
More about terazosin
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 39 Reviews
- Drug class: antiadrenergic agents, peripherally acting
- FDA Alerts (1)
Consumer resources
Other brands: Hytrin
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
